These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32746485)

  • 1. Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?
    Mayer O; Seidlerová J; Bruthans J; Gelžinský J; Rychecká M; Mateřánková M; Karnosová P; Wohlfahrt P; Cífková R; Filipovský J
    Horm Metab Res; 2020 Dec; 52(12):861-868. PubMed ID: 32746485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease.
    Li Q; Lu Y; Sun L; Yan J; Yan X; Fang L; Li M; Fan Z
    Metabolism; 2012 Dec; 61(12):1803-8. PubMed ID: 22789446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
    Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis.
    Yang L; Li B; Zhao Y; Zhang Z
    Lipids Health Dis; 2019 Dec; 18(1):227. PubMed ID: 31870374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Mateřánková M; Gelžinský J; Rychecká M; Opatrný J; Wohlfahrt P; Kučera R; Trefil L; Cífková R; Filipovský J; Vermeer C
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):540-551. PubMed ID: 33257192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients.
    Maiolino G; Cesari M; Sticchi D; Zanchetta M; Pedon L; Antezza K; Pessina AC; Rossi GP
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3333-40. PubMed ID: 18697874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
    Kotecha D; Flather MD; Atar D; Collins P; Pepper J; Jenkins E; Reid CM; Eccleston D;
    BMC Med; 2019 Apr; 17(1):72. PubMed ID: 30943979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and mortality in patients undergoing coronary angiography.
    Pilz S; Mangge H; Wellnitz B; Seelhorst U; Winkelmann BR; Tiran B; Boehm BO; März W
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4277-86. PubMed ID: 16912132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
    Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and long-term mortality in coronary artery disease participants and controls.
    Hascoet S; Elbaz M; Bongard V; Bouisset F; Verdier C; Vindis C; Genoux A; Taraszkiewicz D; Perret B; Galinier M; Carrié D; Ferrières J; Ruidavets JB
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):e19-29. PubMed ID: 23139295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery disease.
    Mayer O; Bruthans J; Seidlerová J; Gelžinský J; Kučera R; Karnosová P; Mateřánková M; Wohlfahrt P; Cífková R; Filipovský J
    Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2137-2146. PubMed ID: 35843790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
    Hsu CY; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Chou RH; Huang CY; Huang PH; Leu HB; Yin WH; Wu CC; Lin SJ; Chen JW
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1240-1252. PubMed ID: 30943772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renal-anemia syndrome.
    Hara K; Uchida T; Takebayashi K; Sakai Y; Inoue T; Inukai T; Takayanagi K; Aso Y
    Intern Med; 2011; 50(24):2953-60. PubMed ID: 22185985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between adiponectin production in coronary circulation and future cardiovascular events in patients with coronary artery disease.
    Kawagoe J; Ishikawa T; Iwakiri H; Date H; Imamura T; Kitamura K
    Int Heart J; 2014; 55(3):239-43. PubMed ID: 24806386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay Between Adiponectin and Pro-Atrial Natriuretic Peptide and Prognosis in Patients With ST-Segment Elevation Myocardial Infarction.
    Lindberg S; Jensen JS; Hoffmann S; Pedersen SH; Iversen AZ; Galatius S; Frystyk J; Flyvbjerg A; Goetze JP; Bjerre M; Mogelvang R
    Am J Cardiol; 2015 Nov; 116(9):1340-5. PubMed ID: 26361828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke.
    Tu WJ; Qiu HC; Liu YK; Liu Q; Zeng X; Zhao J
    Cardiovasc Diabetol; 2020 Aug; 19(1):125. PubMed ID: 32771014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.